Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ).
Shanghai Bio-heart Biological Technology Co., Ltd. has announced a meeting for its H shareholders to consider and approve proposed amendments to the company’s articles of association. This meeting reflects the company’s ongoing efforts to align its governance framework with strategic objectives, potentially impacting its market operations and stakeholder engagement.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-heart Biological Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the biotechnology sector.
YTD Price Performance: -8.54%
Average Trading Volume: 26,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$627.8M
For a thorough assessment of 2185 stock, go to TipRanks’ Stock Analysis page.